DUBLIN, Jan. 10, 2023 (GLOBE NEWSWIRE) — ‘Extremely Strong API Market Outlook’ Report Released of ResearchAndMarkets.com Recruitment.
Highly Potent Active Pharmaceutical Ingredients (HPAPIs) are a growing area for pharmaceutical companies.
This report provides an overview of the current market dynamics for high containment manufacturing and a five-year market outlook projected by survey respondents (all HPAPI manufacturing decision makers at the sponsoring organizations).
Key statistics include the classification of respondents’ companies’ advanced containment assets, and the percentage of small molecule portfolios requiring advanced containment manufacturing, respondents’ development pipelines and those in the market that require advanced containment. It includes the number of compounds, which therapeutic area they are using. Targeted design and prevalence of outsourcing for each type of advanced containment asset.
As a pharmaceutical innovator, discover how your peers are selecting service providers and which aspects of the manufacturing process have been the most challenging. As a CDMO, see how your capabilities and marketing message align with what a very powerful manufacturing outsourcer sees as important, as well as the main reason the CDMO loses bids for his HPAPI project. Judge.
content of study:
Drug developer:
-
Gain insight into where the very strong drug substance industry is headed in the next five years in terms of outsourcing penetration across various manufacturing activities and highly contained compound classes
-
Understand the CDMO usage patterns of your industry peers to identify whether additional outsourcing benefits may be available to your organization
-
Learn the criteria peers use to scientifically and strategically assess CDMOs for highly competitive drug substance projects
Contract manufacturer:
-
Identify which CDMO attributes led to successful outsourcing relationships, factors that caused service providers to lose bids, and factors that truly drive sponsor satisfaction, and evaluate internally based on these metrics .
-
Identify changes in demand for outsourced activities and services to prepare for future needs
-
Understand the dynamics of different buyer groups and develop targeted marketing to better position your company to win business by speaking directly to their unique needs
Main topics:
Main topics:
How to use this report
Analysis Note: Advanced Containment Requirements
prologue
methodology
Respondent demographics and qualifications
-
Participant geography
-
Participating company size
-
Participation criteria
main section
market dynamics
-
Main section points
-
High Containment Pipeline and Portfolio
-
Percentage of very potent small molecule assets
-
small molecule assets
-
Strong Asset Type
-
very strong product requirements
-
Target disease area
-
dosage form
-
occupational exposure limit
outsourcing practice
-
Main section points
-
outsourcing drivers
-
Using CDMO by stage
-
Possibility to outsource advanced containment manufacturing
-
Outsourced High Containment Manufacturing Now and in 5 Years
-
A very powerful outsourced asset
-
High Potential Outsourcing Activities
-
HPAPI CDMO Utilization
-
Annual Outsourcing Spend
Provider selection and recognition
-
Main section points
-
Timing of CDMO selection
-
Sector influence on CDMO selection
-
Using Preferred Provider
-
Top 5 CDMO Selection Attributes
-
CDMO Satisfaction Factors
-
Why CDMOs Lost Bids
trends, predictions, preferences
-
Main section points
-
difficult field
-
Biggest Outsourcing Challenge – No Prompts
-
Investment in technology and infrastructure
research data
-
Possibility to outsource advanced containment manufacturing
-
Percentage of very potent small molecule assets
-
Very strong asset forecast
-
A very powerful outsourced asset
-
OEL limit
-
very powerful classification
-
very strong product requirements
-
process analysis
-
Potent dosage form
-
Target disease area
-
outsourcing drivers
-
Outsourced High Containment Manufacturing Now and in 5 Years
-
High Potential Outsourcing Activities
-
HPAPI CDMO Utilization
-
Using Preferred Provider
-
Using CDMO by stage
-
Timing of CDMO selection
-
The Importance of Using the Same CDMO for Development and Commercial
-
CDMO selection attributes
-
CDMO Satisfaction Factors
-
Biggest Outsourcing Challenge
-
difficult field
-
Department influence on CMO choice
-
Investment in technology and infrastructure
-
Why CDMOs Lost Bids
-
Annual Outsourcing Spend
demographics
-
Company size and revenue
-
office location
-
Molecular involvement and assets
-
decision-making responsibility
-
Potent compounds in development
-
Very Potent Compounds on the Market
-
Involvement by Molecule Type
For more information on this report, please visit https://www.researchandmarkets.com/r/11rfph.
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. It provides up-to-date data on international and regional markets, key industries, top companies, new products and latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
